These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glioblastoma metastatic to the ovary, a very different Krukenberg tumor? Bonomi RE; Kovoor J; Zaki M; Szlaczky M; Christensen M; Kupsky W; Barger G; Miller S; Dominello MM Pract Radiat Oncol; 2018; 8(6):373-375. PubMed ID: 29861347 [No Abstract] [Full Text] [Related]
4. Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations. Bohdiewicz PJ; Scott GC; Juni JE; Fink-Bennett D; Wilner F; Nagle C; Dworkin HJ Clin Nucl Med; 1995 Mar; 20(3):230-6. PubMed ID: 7750217 [TBL] [Abstract][Full Text] [Related]
6. Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer. Beets G; Penninckx F; Schiepers C; Filez L; Mortelmans L; Kerremans R; Aerts R; De Roo M Br J Surg; 1994 Nov; 81(11):1666-70. PubMed ID: 7827902 [TBL] [Abstract][Full Text] [Related]
7. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. Ruers TJ; Langenhoff BS; Neeleman N; Jager GJ; Strijk S; Wobbes T; Corstens FH; Oyen WJ J Clin Oncol; 2002 Jan; 20(2):388-95. PubMed ID: 11786565 [TBL] [Abstract][Full Text] [Related]
8. The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Lai DT; Fulham M; Stephen MS; Chu KM; Solomon M; Thompson JF; Sheldon DM; Storey DW Arch Surg; 1996 Jul; 131(7):703-7. PubMed ID: 8678767 [TBL] [Abstract][Full Text] [Related]
9. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. Willkomm P; Bender H; Bangard M; Decker P; Grünwald F; Biersack HJ J Nucl Med; 2000 Oct; 41(10):1657-63. PubMed ID: 11037995 [TBL] [Abstract][Full Text] [Related]
10. Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG). Hubner KF; McDonald TW; Niethammer JG; Smith GT; Gould HR; Buonocore E Gynecol Oncol; 1993 Nov; 51(2):197-204. PubMed ID: 8276294 [TBL] [Abstract][Full Text] [Related]
11. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557 [TBL] [Abstract][Full Text] [Related]
12. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan. Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969 [TBL] [Abstract][Full Text] [Related]
14. Jamison DK; Butler KA; Stucky CH; Camoriano JK; Yang M Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(5):327-329. PubMed ID: 30366729 [No Abstract] [Full Text] [Related]
15. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. Findlay M; Young H; Cunningham D; Iveson A; Cronin B; Hickish T; Pratt B; Husband J; Flower M; Ott R J Clin Oncol; 1996 Mar; 14(3):700-8. PubMed ID: 8622014 [TBL] [Abstract][Full Text] [Related]
16. Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma. Bender H; Kirst J; Palmedo H; Schomburg A; Wagner U; Ruhlmann J; Biersack HJ Anticancer Res; 1997; 17(3B):1687-92. PubMed ID: 9179219 [TBL] [Abstract][Full Text] [Related]
17. Imaging in secondary tumors of the ovary. Karaosmanoglu AD; Onur MR; Salman MC; Usubutun A; Karcaaltincaba M; Ozmen MN; Akata D Abdom Radiol (NY); 2019 Apr; 44(4):1493-1505. PubMed ID: 30361868 [TBL] [Abstract][Full Text] [Related]
18. Computed tomography of Krukenberg tumors. Cho KC; Gold BM AJR Am J Roentgenol; 1985 Aug; 145(2):285-8. PubMed ID: 2992252 [TBL] [Abstract][Full Text] [Related]
20. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]